Auswahl an Publikationen

Roboter Chirurgie (DaVinci) 

 

Robot-assisted partial nephrectomy: systematic review of functional results.

Foerster B, Kimura S, Vartolomei MD, Abufaraj M, Gust K, Fajkovic H, Shariat SF, Seitz C.

Curr Opin Urol. 2018 Mar;28(2):123-131.

 

Oncologic outcomes after minimally invasive surgery for cT1 renal masses: a comprehensive review.

Vartolomei MD, Foerster B, Kimura S, Autorino R, Shariat SF, Seitz C.

Curr Opin Urol. 2018 Mar;28(2):132-138.

 

[The Clavien-Dindo classification of complications used for radical prostatectomy].

Hiess M, Ponholzer A, Lamche M, Schramek P, Seitz C.

Wien Med Wochenschr. 2014 Aug;164(15-16):297-301. doi: 10.1007/s10354-014-0264-2. Epub 2014 Jun 5.

 

A multinational, multi-institutional study comparing positive surgical margin rates among 22393 open, laparoscopic, and robot-assisted radical prostatectomy patients.

Sooriakumaran P, Srivastava A, Shariat SF, Stricker PD, Ahlering T, Eden CG, Wiklund PN, Sanchez-Salas R, Mottrie A, Lee D, Neal DE, Ghavamian R, Nyirady P, Nilsson A, Carlsson S, Xylinas E, Loidl W, Seitz C, Schramek P, Roehrborn C, Cathelineau X, Skarecky D, Shaw G, Warren A, Delprado WJ, Haynes AM, Steyerberg E, Roobol MJ, Tewari AK.

Eur Urol. 2014 Sep;66(3):450-6.

 

Prostatakrebs

Mathieu R, Lucca I, Mbeutcha A, Seitz C, Karakiewicz P, Sun M, Montorsi F, Briganti A, Rouprêt M, Robinson B, Xylinas E, Shariat S. Valeur pronostique de Caveolin-1 dans le cancer de prostate : une étude multicentrique internationale. Prog Urol. 2015 Nov;25(13):741-2.

 

Sevcenco S, Mathieu R, Baltzer P, Klatte T, Fajkovic H, Seitz C, Karakiewicz PI, Rouprêt M, Rink M, Kluth L, Trinh QD, Loidl W, Briganti A, Scherr DS, Shariat SF. The prognostic role of preoperative serum C-reactive protein in predicting the biochemical recurrence in patients treated with radical prostatectomy.

Prostate Cancer Prostatic Dis. 2016 Jun;19(2):163-7.

 

Mathieu R, Lucca I, Vartolomei MD, MBeutcha A, Klatte T, Seitz C, Karakiewicz PI, Fajkovic H, Sun M, Lotan Y, Montorsi F, Briganti A, Rouprêt M, Margulis V, Rink M, Rieken M, Kenner L, Susani M, Wolgang L, Shariat SF.

Role of Survivin expression in predicting biochemical recurrence after radical prostatectomy: a multi-institutional study.

BJU Int. 2016 Mar 4. doi: 10.1111/bju.13472.

 

Fajkovic H, Mathieu R, Lucca I, Hiess M, Hübner N, Al Hussein Al Awamlh B, Lee R, Briganti A, Karakiewicz P, Lotan Y, Roupret M, Rink M, Kluth L, Loidl W, Seitz C, Klatte T, Kramer G, Susani M, Shariat SF.

Validation of lymphovascular invasion is an independent prognostic factor for biochemical recurrence after radical prostatectomy.

 

Mathieu R, Moschini M, Beyer B, Gust KM, Seisen T, Briganti A, Karakiewicz P, Seitz C, Salomon L, de la Taille A, Rouprêt M, Graefen M, Shariat SF. Prognostic value of the new Grade Groups in Prostate Cancer: a multi-institutional European validation study. Prostate Cancer Prostatic Dis. 2017 Jan 10. doi: 10.1038/pcan.2016.66. [Epub ahead of print]

 

Mathieu R, Lucca I, Vartolomei MD, Mbeutcha A, Klatte T, Seitz C, Karakiewicz PI, Fajkovic H, Sun M, Lotan Y, Montorsi F, Briganti A, Rouprêt M, Margulis V, Rink M, Rieken M, Kenner L, Susani M, Wolgang L, Shariat SF.

Role of survivin expression in predicting biochemical recurrence after radical prostatectomy: a multi-institutional study. BJU Int. 2017 Feb;119(2):234-238. 

 

Rieken M, Kluth LA, Seitz C, Abufaraj M, Foerster B, Mathieu R, Karakiewicz PI, Bachmann A, Briganti A, Rouprê M, Gönen M, Shariat SF, Seebacher V.

External Validation of the Pathologic Nodal Staging Score for Prostate Cancer: A Population-based Study.

Clin Genitourin Cancer. 2017 Aug 24.

 

Grubmüller B, Baltzer P, D'Andrea D, Korn S, Haug AR, Hacker M, Grubmüller KH, Goldner GM, Wadsak W, Pfaff S, Babich J, Seitz C, Fajkovic H, Susani M, Mazal P, Kramer G, Shariat SF, Hartenbach M.

68Ga-PSMA 11 ligand PET imaging in patients with biochemical recurrence after radical prostatectomy - diagnostic performance and impact on therapeutic decision-making.

 

Özsoy M, Moschini M, Fajkovic H, Soria F, Seitz C, Klatte T, Gust K, Briganti A, Karakiewicz PI, Roupret M, Kramer G, Shariat SF.

Elevated preoperative neutrophil-lymphocyte ratio predicts upgrading at radical prostatectomy.

Prostate Cancer Prostatic Dis. 2018 Apr;21(1):100-105

 

Özsoy M, D'Andrea D, Moschini M, Foerster B, Abufaraj M, Mathieu R, Briganti A, Karakiewicz PI, Roupret M, Seitz C, Czech AK, Susani M, Shariat SF.

Tertiary Gleason pattern in radical prostatectomy specimens is associated with worse outcomes than the next higher Gleason score group in localized prostate cancer.

Urol Oncol. 2018 Apr;36(4):158.e1-158.e6. doi: 10.1016/j.urolonc.2017.12.003. Epub 2017 Dec 27.

 

 

Nierensteine / Harnleitersteine

Seitz C. Fajkovic H. Waldert M. Tanovic E. Remzi M.  Kramer G. Marberger M. Extracorporeal shock wave lithotripsy in the treatment of proximal ureteral stones: Does the presence and degree of hydronephrosis affect success?
Eur Urol 2006;49(2):378-83. Epub 2005 Dec 9.

Seitz C. Fajkovic H. Remzi M. Waldert M. Özsoy M. Kramer G. Marberger M. Rapid extracorporeal shock wave lithotripsy treatment after a first colic episode correlates with accelerated ureteral stone clearance.
Eur Urol 2006;49(6):1099-106 Epub 2005 Dec 28

Seitz C. Interventionelle Steintherapie.
Young Urology: 2007;3:4-11.

Seitz C. Reply to Autorino, Osorio and Lima’s letter to the Editor re: Rapid extracorporeal shock wave lithotripsy for proximal ureteral calculi in colic versus non-colic patients.
Eur Urol: 2007 52(4):1265-6.

Memarsadeghi M, Schaefer-Prokop C, Prokop M, Helbich TH, Seitz C, Noebauer-Huhmann IM, Heinz-Peer G. Unenhanced MDCT in patients with suspected urinary stone disease: do coronal reformations improve diagnostic performance?

AJR Am J Roentgenol. 2007 Aug;189(2):W60-4.

Seitz C, Tanovic E, Kikic Z, Memarsadeghi M, Fajkovic H: Rapid extracorporeal shock wave lithotripsy for proximal ureteral calculi in colic versus noncolic patients.
Eur Urol 2007 Oct;52(4):1223-7. Epub 2007 Feb 12.

Seitz C, Tanovic E, Kikic Z, Fajkovic H: Impact of stone size, location, composition, impaction, and hydronephrosis on the efficacy of holmium:YAG-laser ureterolithotripsy.
Eur Urol 2007 Dec;52(6):1751-7. Epub 2007 Apr 18.

Seitz C, Memarsadeghi M, Fajkovic H, Tanovic E: Secondary signs of non-enhanced CT prior to laser ureterolithotripsy: is treatment outcome predictable?
J Endourol 2008 Mar;22(3):415-8.

Seitz C.
Editorial comment on: training in percutaneous nephrolithotomy-a critical
review. Eur Urol 2008 Nov;54(5):1002. Epub 2008 Mar 28. No abstract available.
 
Seitz C. Editorial comment
on: endoscopic combined intrarenal surgery in Galdakao-modified supine Valdivia
position: a new standard for percutaneous nephrolithotomy?
Eur Urol 2008 Dec;54(6):1402-3. Epub 2008 Aug 8.

Seitz C, Martini T, Berner L, Signorello D, Galantini A, Pycha A. Efficacy and treatment outcome of a new electromagnetic lithotripter for upper urinary tract calculi. J Endourol. 2008 Nov;22(11):2519-25.

Seitz C, Liatsikos E, Porpiglia F, Tiselius HG, Zwergel U: Medical therapy to facilitate
the passage of stones: what is the evidence?
Eur Urol 2009 Sep;56(3):455-71. 


Seitz C, Fritsche HM, Siebert T, Martini T, Wieland WF, Pycha A, Burger M: Novel electromagnetic lithotriptor for upper tract stones with and without a ureteral stent. J Urol 2009 Oct;182(4):1424-9. Epub 2009 Aug 15.

Türk C, Knoll T, Petrik A, Sarica K, Seitz C, Straub M, Traxer O.
European Guideline Working Panel Guidelines on Urolithiasis EAU Barcelona 2010

Seitz C.
Medical Expulsive Therapy of Ureteral Calculi and Supportive therapy
after Extracorporeal Shock Wave Lithotripsy.
Eur Urol Suppl 2010 (9) 807-13

Türk C, Knoll T, Petrik A, Sarica K, Seitz C, Straub M, Traxer O.
European Guideline Working Panel Guidelines on Urolithiasis EAU Vienna 2011

 

Türk C, Knoll T, Petrik A, Sarica K, Seitz C, Straub M, Traxer O.
European Guideline Working Panel Guidelines on Urolithiasis EAU Paris 2012

 

Seitz C, Desai M, Häcker A, Hakenberg OW, Liatsikos E, Nagele U, Tolley D. Incidence, Prevention, and Management of Complications Following Percutaneous   Nephrolitholapaxy. Eur Urol. 2012

 

Hiess M, Seitz C. Medikamentöse Therapie der Nierenkolik
Spektrum Urologie 2012

 

Seitz C, Fajkovic H. Medikamentöse Passageerleichterung von Uretersteinen:
Ein Metaanalyse-Update Spektrum Urologie 2012

 

Türk C, Knoll T, Petrik A, Sarica K, Seitz C, Skolarikos A, Straub M
European Guideline Working Panel Guidelines on Urolithiasis 2013

 

Seitz C, Fajkovic H

Epidemiological gender specific aspects of urolithiasis

World J Urol 2013

 

Seitz C, Fajkovic H

Training in ureteroscopy for urolithiasis.

Arab Journal of Urology 2013

 

Schoenthaler M, Buchholz N, Farin E, Ather H, Bach C, Bach T, Denstedt JD, Fritsche HM, Grasso M, Hakenberg OW, Herwig R, Knoll T, Kuehhas FE, Liatsikos E, Liske P, Marberger M, Osther PJ, Santos JM, Sarica K, Seitz C, Straub M, Traxer O, Trinchieri A, Turney B, Miernik A. The Post-Ureteroscopic Lesion Scale (PULS): a multicenter video-based evaluation of inter-rater   reliability. World J Urol. 2014 Aug;32(4):1033-40. Epub 2013 Oct 18.

 

Impact of gender on success and complication rates after ureteroscopy.

Ozsoy M, Acar O, Sarica K, Saratlija-Novakovic Z, Fajkovic H, Librenjak D, Esen T, Scheffbuch N,Seitz C.

World J Urol. 2014 Nov 12. [Epub ahead of print]

 

Metabolic Evaluation and Recurrence Prevention for Urinary Stone Patients: EAU Guidelines.

Skolarikos A, Straub M, Knoll T, Sarica K, Seitz C, Petřík A, Türk C.

Eur Urol. 2014 Nov [Epub ahead of print]

 

 

Tract Sizes in Miniaturized Percutaneous Nephrolithotomy: A Systematic Review from the European Association of Urology Urolithiasis Guidelines Panel.

 

 

Ruhayel Y, Tepeler A, Dabestani S, MacLennan S, Petřík A, Sarica K, Seitz C, Skolarikos A, Straub M, Türk C, Yuan Y, Knoll T.

Eur Urol. 2017 Feb 22.

 

Medical Expulsive Therapy for Ureterolithiasis: The EAU Recommendations in 2016.

Türk C, Knoll T, Seitz C, Skolarikos A, Chapple C, McClinton S; 

European Association of Urology. Eur Urol. 2017 Apr;71(4):504-507. 

 

Tract Sizes in Miniaturized Percutaneous Nephrolithotomy: A Systematic Review from the European Association of Urology Urolithiasis Guidelines Panel.

 

 

Ruhayel Y, Tepeler A, Dabestani S, MacLennan S, Petřík A, Sarica K, Seitz C, Skolarikos A, Straub M, Türk C, Yuan Y, Knoll T.

Eur Urol. 2017 Aug;72(2):220-235.

 

Grey Zones in Urolithiasis Guidelines.

 

 

Türk C, Knoll T, Petřík A, Sarica K, Seitz C, Skolarikos A.

Eur Urol Focus. 2017 Feb;3(1):144-146.

 

Medical Expulsive Therapy in Urolithiasis: A Review of the Quality of the Current Evidence.

 

 

Skolarikos A, Ghani KR, Seitz C, Van Asseldonk B, Bultitude MF.

Eur Urol Focus. 2017 Feb;3(1):27-45.

 

Metabolic Work-up of Patients with Urolithiasis: Indications and Diagnostic Algorithm.

 

 

Tiselius HG, Daudon M, Thomas K, Seitz C.

Eur Urol Focus. 2017 Feb;3(1):62-71.

 

Histological changes caused by the prolonged placement of ureteral access sheaths: an experimental study in porcine model.

Özsoy M, Kyriazis I, Vrettos T, Kotsiris D, Ntasiotis P, Seitz C, Evangelos L, Panagiotis K.

Urolithiasis. 2017 Oct 12. doi: 10.1007/s00240-017-1007-9. [Epub ahead of print]

 

The evaluation of radiologic methods for access guidance in percutaneous nephrolithotomy: a systematic review of the literature.

 

 

Breda A, Territo A, Scoffone C, Seitz C, Knoll T, Herrmann T, Brehmer M, Osther PJS, Liatsikos E.

Scand J Urol. 2017 Nov 12:1-6. 

 

The stone surgeon in the mirror: how are German-speaking urologists treating large renal stones today?

 

Schoenthaler M, Hein S, Seitz C, Türk C, Danuser H, Vach W, Miernik A.

World J Urol. 2018 Mar;36(3):467-473.

 

Re: Do JJ Stents Increase the Effectiveness of Extracorporeal Shock Wave Lithotripsy for Pediatric Renal Stones?

Seitz C. 

Urol Int. 2018;100(3):353-354. doi: 10.1159/000487197. Epub 2018 Mar 7.

 

Re: Zhangqun Ye, Guohua Zeng, Huan Yang, et al. Efficacy and Safety of Tamsulosin in Medical Expulsive Therapy for Distal Ureteral Stones with Renal Colic: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial.

 

Seitz C.

 

Eur Urol. 2018 Jan 10.

 

Gutartige Prostatavergrößerung (BPH)

Djavan B., Seitz C, Ghawidel K, Basharkhah A, Bursa B,
Hruby S, Marberger M:
Temporary intraprostatic Prostatic bridge catheter
compared with neoadjuvant and
adjuvant alpha-blockade to improve early
results of high energy TUMT.
Urology. 1999 54: 73-80

Djavan B., Shariat S., Fakhari M., Ghawidel K, Seitz
C., Roehrborn C.G., Partin AW.,  Marberger M: Neoadjuvant and adjuvant
alpha-blockade in patients undergoing HE TUMT for benign prostatic hyperplasia:
a randomized prospective clinical trial.
Urology, 1999 53:
251-9

Djavan B., Seitz C., Fakhari M, Ghawidel K, Marberger M: Prevention of temporary prostatic obstruction after high-energy transurethral microwave thermotherapy by placement of an intraurethral prostatic bridge catheter.
Progrès d`Urologique.(Paris),
1999 (9): 261-70

Djavan B., Seitz C., Ghawidel K., Basharkhah A, Bursa B, Hruby S., Marberger M:
High  energy transurethral microwave thermotherapy in patients with acute
urinary retention due to benign prostatic hyperplasia.
Urology, 1999 54: 18-22

Djavan B., Lin V., Seitz C., Kramer G, Kaplan P., Richier J, Marberger M., McConnell JD: Elastin gene expression in benign prostatic hyperplasia (BPH).
Prostate 1999 Sep;40(4):242-247

Djavan B., Madersbacher S., Klingler HC., Ghawidel K., Basharkhah A, Hruby S., Seitz C., Marberger M: Outcome analysis of minimal invasive treatment options for BPH.
Techniques in Urology 1999 Mar;5(1):12-20. Review

Djavan B, Bursa B, Basharkhah A, Seitz C, Remzi M,
Ghawidel K, Hruby S, Marberger M. Pretreatment prostate-specific antigen as an outcome predictor of targeted transurethral microwave thermotherapy. Urology 2000 Jan;55(1):51-7

Djavan B, Seitz C, Roehrborn C, Remzi M, Hruby S, Marberger M. Targeted Transurethral Microwave Thermotherapy versus a-Blockade in Benign Prostatic Hyperplasia (BPH): Outcomes at 18 Months.
Urology 2001 Jan;57(1):66-70.

Seitz C, Djavan B, Marberger M.
Morphological and biological predictors for treatment outcome of transurethral microwave thermotherapy.
Current opinion of Urology 2002 Jan;12(1):25-32.

Djavan B., Seitz
C., Marberger M. Transurethral microwave thermotherapy.
Atlas Urol Clin 2002 10:1-11.

Seitz, C.
Editorial comment on: The Correlation between Metabolic Syndrome and
Prostatic Growth in Patients with Benign Prostatic Hyperplasia.
Eur Urol 2007;51:199-206

Seitz C, Remzi M, Djavan B, Roehrborn CG. Advances in the medical treatment of prostate cancer,
bladder cancer, renal cell cancer and benign prostatic hyperplasia.
Rev. Urol. 2003; 5(2):90-110



Brunken C, Seitz C, Tauber S, Schmidt R. Transurethral Green Lightlaser enucleation of theprostate-a feasibilitystudy.

J Endourol. 2011 Jul;25(7):1199-201.

 

Brunken C, Seitz C. (Contributed equally), Woo HH. A Systematic Review of Experience of 180W XPS GreenLight Laser Vaporization of the Prostate in 1640 men. BJU Int. 2014 Oct 13.



Prostatabiopsie / Prostatakarzinom

Djavan B., Zlotta A., Kratzik C., Remzi M., Seitz C., Schulman CC., Marberger M: PSA, PSA density, PSA density of transition zone, Free to total PSA ratio and PSA velocity for prostate detection in men with total PSA of 2.5 to 4ng/ml. Urology. 1999 Sep;54(3):517-22

Djavan B, Bursa B, Seitz C, Soeregi K, Remzi  M, Basharkhah A,
Wolfram  R, Marberger  M: Insulin like growth factor 1 (IGF-1), IGF-1density and IGF-1/PSA ratio for prostate cancer detection.
Urology. 1999 Oct;54(4):603-6

Djavan B, Seitz C, Remzi M., Ghawidel K., Basharkhah A., Hruby S., Bursa B., Marberger M:
Combinations of PSA based diagnostic tests for prostate cancer detection.
Techniques in Urology 1999 Jun;5(2):71-6

Djavan B, Zlotta A, Waldert M, Dobronski P, Seitz C, Remzi M,
Borkowski A, Schulman C, Marberger M. Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study.
J Urology 2001 Sep;166(3):856-60

Djavan B, Waldert M, Seitz C, Marberger M. Insulin-like growth factors and prostate cancer. World J Urology 2001 Aug;19(4):225-33.

Djavan B, Ravery V, Zlotta A, Dobronski P, Dobrovits M, Fakhari M, Seitz C, Susani M, Borkowski A, Boccon-Gibod L, Schulman CC, Marberger M:
Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop?
J Urology 2001 Nov;166(5):1679-83.

Djavan B, Remzi M, Zlotta A, Seitz C, Snow P, Marberger M. Novel artificial neural network for early detection of prostate cancer.
J Clinical Oncology 2002 Feb 15;20(4):921-9.

Seitz C, Remzi M, Djavan B, Roehrborn CG.
Advances in the medical treatment of prostate cancer, bladder cancer, renal cell cancer and benign prostatic hyperplasia.
Rev. Urol. 2003; 5(2):90-110

Remzi M., Djavan B., Wammak R., Momeni M., Seitz C., Erne B., Dobrovits M., Alavi S., Marberger M. Can total and transition zone volume of the prostate determine whether to perform a repeat biopsy?
Urology 2003 Jan;61(1):161-6.

Seitz C., Palermo S., Djavan B. Prostate biopsy.
Minerva Urol Nefrol. 2003 Dec;55(4):205-218.

Seitz C., Djavan B. Prävention urologischer Erkrankungen: Prostatakarzinom J. für Urologie/Urogynäkologie Sonderheft 2004;(7):11-3.

Seitz C., Remzi, M., Djavan B. Immediate treatment after PSA Progression.
UroOnkologia 2005;(2):42-52

Seitz C., Remzi M., Djavan B. Immediate Treatment after PSA Progression.
Eur Urol Suppl 2005 (4) 28-42.

Seitz C., Djavan B. Marqueurs biologiques du cancer de la prostate.
Annales d’Urologie 2006;40(6):329-35.

Seitz C., Djavan B. Biomarkers for Prostate Cancer.
EMC treatise of urology 2006 (4) N° 150

Seitz C, Remzi M, Djavan B, Roehrborn CG:
Advances in the Medical Treatment of Prostate Cancer, Bladder Cancer, Renal Cell Cancer, and Benign Prostatic Hyperplasia: Highlights from the XVIIth Congress of the European Association of Urology, Birmingham, UK, February 23-26, 2002.
Rev Urol 2003 Spring;5(2):90-110.

Seitz C, Djavan B. Biological markers of prostate cancer
Ann Urol (Paris) 2006 Dec;40(6):329-35. Review. French.

Rom M, Pycha A, Wiunig C, Reissigl A, Waldert M, Klatte T, Remzi M, Seitz C.

Prospective Randomized Multicenter Study Comparing Prostate Cancer Detection Rates of End-fire and Side-fire Transrectal Ultrasound Probe Configuration.

Urology. 2012 May 10. [Epub ahead of print]

 

Sooriakumaran P, Srivastava A, Shariat SF, Stricker PD, Ahlering T, Eden CG, Wiklund PN, Sanchez-Salas R, Mottrie A, Lee D, Neal DE, Ghavamian R, Nyirady   P, Nilsson A, Carlsson S, Xylinas E, Loidl W, Seitz C, Schramek P, Roehrborn C,   Cathelineau X, Skarecky D, Shaw G, Warren A, Delprado WJ, Haynes AM,   Steyerberg E, Roobol MJ, Tewari AK.

A Multinational, Multi-institutional Study Comparing Positive Surgical Margin Rates   Among 22393 Open, Laparoscopic, and Robot-assisted Radical Prostatectomy Patients. Eur Urol. 2014 Sep;66(3):450-6

 

Kluth LA, Abdollah F, Xylinas E, Rieken M, Fajkovic H, Seitz C, Sun M,   Karakiewicz PI, Schramek P, Herman MP, Becker A, Hansen J, Ehdaie B,   Loidl W, Pummer K, Lee RK, Lotan Y, Scherr DS, Seiler D, Ahyai SA, Chun FK, Graefen M, Tewari A, Nonis A, Bachmann A, Montorsi F, Gönen   M, Briganti A, Shariat SF. Clinical nodal staging scores for prostate cancer: a proposal for preoperative   risk assessment.

Br J Cancer. 2014 Jul 15;111(2):213-9. Epub 2014 Jul 8.

 

Hiess M, Ponholzer A, Lamche M, Schramek P, Seitz C. The Clavien-Dindo classification of complications used for radical prostatectomy. Wien Med Wochenschr. 2014 Jun 5. [Epub ahead of print] German.

 

Rieken M, Kluth LA, Xylinas E, Fajkovic H, Becker A, Karakiewicz PI, Herman M, Lotan Y, Seitz C, Schramek P, Remzi M, Loidl W, Pummer K, Lee RK, Faison T, Scherr DS, Kautzky-Willer A, Bachmann A, Tewari A, Shariat SF.   Association of diabetes mellitus and metformin use with biochemical   recurrence in patients treated with radical prostatectomy for prostate cancer. World J Urol. 2014 Aug;32(4):999-1005.

 

Validation of tertiary Gleason pattern 5 in Gleason score 7 prostate cancer as an independent predictor of biochemical recurrence and development of a prognostic model.

Lucca I, Shariat SF, Briganti A, Lotan Y, Roehrborn CG, Montorsi F, Remzi M, Seitz C, Fajkovic H, Klingler C, Karakiewicz PI, Sun M, Rouprêt M, Loidl W, Pummer K, Klatte T. Urol Oncol. 2014 Oct 23. [Epub ahead of print]

 

Multi-institutional validation of the prognostic value of Ki-67 labeling index in patients treated with radical prostatectomy.

Mathieu R, Shariat SF, Seitz C, Karakiewicz PI, Fajkovic H, Sun M, Lotan Y, Scherr DS, Tewari A, Montorsi F, Briganti A, Rouprêt M, Lucca I, Margulis V, Rink M, Kluth LA, Rieken M, Bachman A, Xylinas E, Robinson BD, Bensalah K, Margreiter M. World J Urol. 2014 Oct 26. [Epub ahead of print]

 

 

Nierenkarzinom

Seitz C, Remzi M, Djavan B, Roehrborn CG. Advances in
the medical treatment of prostate cancer, bladder cancer, renal cell cancer and benign prostatic hyperplasia.
Rev. Urol. 2003; 5(2):90-110
 
Remzi M, Oszoy M, Klingler HC, Susani M, Waldert M, Seitz C, Schmidbauer J, Marberger M. Are small renal tumors harmless? Analysis of histopathological features according to tumors 4cm or less in diameter.
J Urol 2006:176(3):896-9

Seitz C*, Klatte T; Waldert M, de Martino M, Kikic Z, Böhmig GA, Haitel A, Schmidbauer J, Marberger M, Remzi M: Features and outcomes of renal cell carcinoma of native kidneys in renal transplant recipients.

BJU Int 2009 Oct 10. [Epub ahead of print] *Contributet equally

 

Ploussard G, Xylinas E, Lotan Y, Novara G, Margulis V, Rouprêt M, Matsumoto K, Karakiewicz PI, Montorsi F, Remzi M, Seitz C, Scherr DS, Kapoor A, Fairey AS, Rendon R, Izawa J, Black PC, Lacombe L, Shariat SF, Kassouf W. Validation of mammalian target of rapamycin biomarker panel in patients with clear cell renal cell carcinoma. Cancer. 2014 Sep 


Urothelkarzinome: (Blasen-, Harnleiter-, Nierenbeckenkarzinome)
  
Seitz C, Remzi M, Djavan B, Roehrborn CG. Advances in
the medical treatment of prostate cancer, bladder cancer, renal cell cancer and benign prostatic hyperplasia.
Rev. Urol. 2003; 5(2):90-110

Novara G, Matsumoto K, Kassouf W, Walton TJ, Fritsche HM, Bastian PJ, Martínez Salamanca JI, Seitz C, Lemberger RJ, Burger M,
El-Hakim A, Baba S, Martignoni G, Gupta A, Karakiewicz PI, Ficarra V, Shariat SF: Prognostic Role of Lymphovascular Invasion in Patients with Urothelial Carcinoma of the Upper Urinary Tract: An International Validation Study.
Eur Urol 2010 Jan 6. [Epub ahead of print]

Seitz C, A Gupta, S F Shariat, K Matsumoto,
W Kassouf, T J Walton, H M Fritsche, STritschler, P J Bastian, J I.
Martínez-Salamanca, V Ficarra, P I. Karakiewicz, T Martini, G Novara.
Association of tumor necrosis with pathological features and clinical outcome in 754 Patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma.
J Urol 2010 Nov;184(5):1895-900. Epub 2010 Sep 17

SF. Shariat, RL. Favaretto, A Gupta, HM Fritsche, K Matsumoto, W Kassouf, TJ. Walton, S Tritschler, S Baba, K Matsushita, PJ. Bastian, JM Salamanca, C Seitz, A Pycha, W Otto, PI. Karakiewicz, V Ficarra, G Novara. Gender Differences in Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.

World J of Urol 2010 Oct 1 [Epub ahead of print]

Fritsche HM, Novara G, Burger M, Gupta A, Matsumoto K, Kassouf W, Sircar K, Zattoni F, Walton T, Tritschler S, Baba S, Bastian PJ, Martínez-Salamanca JI, Seitz C, Otto W, Wieland WF, Karakiewicz PI, Ficarra V, Hartmann A, Shariat SF. Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma.
Urol Oncol. 2010 Oct 6. [Epub ahead of print]

Walton TJ, Novara G, Matsumoto K, Kassouf W, Fritsche HM, Artibani W, Bastian PJ, Martínez-Salamanca JI, Seitz C, Thomas SA, Ficarra V, Burger M, Tritschler S, Karakiewicz PI, Shariat SF.Oncological outcomes after laparoscopic and open radical nephroureterectomy: results from an international cohort.
BJU Int. 2010 Nov 15. [Epub ahead of print]

Otto W, Shariat SF, Fritsche HM, Gupta A, Matsumoto K, Kassouf W, Martignoni G, Walton TJ, Tritschler S, Baba S, Bastian PJ, Martínez-Salamanca JI, Seitz C, Pycha A, Burger M, Karakiewicz PI, Ficarra V, Novara G. Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients.
World J Urol. 2011 Jan 20. [Epub ahead of print]

 

ChromeckiTF, Ehdaie B, Novara G, Pummer K, Zigeuner R, Seitz C, Pycha A, Lee RK, Cha EK, Karakiewicz PI, Ng C, Raman JD, Chun FK, Fritsche HM, Matsumoto K, Kassouf W, Walton TJ, Bastian PJ, Martínez-Salamanca JI, Scherr DS, Shariat SF. Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy.
World J Urol. 2011 Aug;29(4):473-80.
 
Matsumoto K, Novara G, Gupta A, Margulis V, Walton TJ, Roscigno M, Ng C, Kikuchi E, Zigeuner R, Kassouf W, Fritsche HM, Ficarra V, Martignoni G, Tritschler S, Rodriguez JC, Seitz C, Weizer A, Remzi M, Raman JD, Bolenz C, Bensalah K, Koppie TM, Karakiewicz PI, Wood CG, Montorsi F, Iwamura M, Shariat SF.   Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study. BJU Int. 2011 Oct;108(8b):E304-E309.

 

Burger M, Shariat SF, Fritsche HM, Martinez-Salamanca JI, Matsumoto K, Chromecki TF, Ficarra V, Kassouf W, Seitz C, Pycha A, Tritschler S, Walton TJ, Novara G. No overtinfluence of lymphadenectomy on cancer-specific survival in organ-confined
versus locally advanced upper urinary tract urothelial carcinoma undergoing
radical nephroureterectomy: a retrospective international, multi-institutional
study. World J Urol. 2011 Aug;29(4):465-72.
 
VerhoestG, Shariat SF, Chromecki TF, Raman JD, Margulis V, Novara G, Seitz C, Remzi M, Rouprêt M, Scherr DS, BensalahK. Predictive factors of recurrence and survival of upper tract urothelial carcinomas.

World J Urol. 2011 Aug;29(4):495-501. Epub 2011 Jun 17.

 

Remzi M, Shariat S, Huebner W, Fajkovic H, Seitz C. Upper urinary tract urothelial carcinoma: what have we learned in the last 4 years?
Ther Adv Urol. 2011 Apr;3(2):69-80.
 
Seitz C, Schramek P. Urothelialcarcinoma of the upper urinary tract: clinical and   pathological criteria and their predictive implications after radical   nephroureterectomy.
Wien Med Wochenschr. 2011 Aug;161(15-16):366-70

 

Martinez-Salamanca JI, Shariat SF, Rodriguez JC, Chromecki TF, Ficarra
V, Fritsche HM, Kassouf W, Matsumoto K, Cabello LO, Seitz C, Tritschler S,
Walton   TJ, Zattoni F, Novara G. Prognostic role of ECOG performance status in patients with urothelialcarcinoma of the upper urinary tract: an international study.
BJU Int. 2011 Aug 24.
 

Yafi FA, Novara G, Shariat SF, Gupta A, Matsumoto K, Walton TJ, Fritsche HM, El-Hakim A, Trischler S, Martínez-Salamanca JI, Seitz C, Ficarra V, Zattoni F, Karakiewicz PI, Kassouf W. Impactof tumour location versus multifocality in patients with upper tract urothelial  carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.

BJU Int. 2011 Dec 16. [Epub ahead of print]

 

FajkovicH, Cha EK, Jeldres C, Donner G, Chromecki TF, Margulis V, Novara G, Lotan Y, Raman JD, Kassouf W, Seitz C, Bensalah K, Weizer A, Kikuchi E, Roscigno M, Remzi M, Matsumoto K, Breinl E, Pycha A, Ficarra V, Montorsi F, Karakiewicz PI, Scherr DS, Shariat SF. Prognostic value of extranodal extension and other lymph node parameters in patients with upper tract urothelial carcinoma.

J Urol. 2012 Jan 14. [Epub ahead of print]

 

Roscigno M, Cha EK, Rink M, Seitz C, Novara G, Chromecki TF, Fritsche HM, Matsumoto K, Walton TJ, Carballido J, Filippo Da Pozzo L, Bertini R, Ficarra V, Otto W, Karakiewicz PI, Pycha A, Fajkovic H, Naspro R, Scherr DS, Montorsi F, Shariat SF. International validation of the prognostic value of subclassification for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvis.

BJU Int. 2012 Feb 20. [Epub ahead of print]

 

XylinasE, Rink M, Cha EK, Clozel T, Lee RK, Fajkovic H, Comploj E, Novara G, Margulis V, Raman JD, Lotan Y, Kassouf W, Fritsche HM, Weizer A, Martinez-Salamanca JI, Matsumoto K, Zigeuner R, Pycha A, Scherr DS, Seitz C, Walton T, Trinh QD, Karakiewicz PI, Matin S, Montorsi F, Zerbib M, Shariat SF; for the Upper Tract Urothelial Carcinoma Collaboration. Impact of Distal Ureter Management on Oncologic Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.

EurUrol. 2012 May 4. [Epub ahead of print]

 
Xylinas E, Rink M, Margulis V, Clozel T, Lee RK, Comploj E, Novara G,

Raman JD, Lotan Y, Weizer A, Roupret M, Pycha A, Scherr DS, Seitz C, Ficarra V, Trinh QD, Karakiewicz PI, Montorsi F, Zerbib M, Shariat SF; UTUC Collaboration. Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy.

BJU Int. 2013 Mar 6. [Epub ahead of print]

 

105  Klatte T, Xylinas E, Rieken M, Kluth LA, Rouprêt M, Pycha A, Fajkovic H, Seitz   C, Karakiewicz PI, Lotan Y, Babjuk M, de Martino M, Scherr DS, Shariat SF. Impact of ABO blood type on outcomes of patients with primary non-muscle-  invasive bladder cancerJ Urol. 2013 Dec 10. [Epub ahead of print]

 

Atiqullah Aziz, Matthias May, Maximilian Burger, Rein-Jüri Palisaar, Quoc-Dien Trinh, Hans-Martin-Fritsche, Michael Rink, Felix Chun, Thomas Martini,   Christian Bolenz, Roman Mayr, Armin Pycha, Philipp Nuhn, Christian Stief,   Vladimir Novotny, Manfred Wirth, Christian Seitz, Joachim Noldus, Christian   Gilfrich, Shahrokh F. Shariat, Sabine Brookman-May, Patrick J. Bastian,   Stefan Denzinger, Michael Gierth and Florian Roghmann, the PROMETRICS   2011 research group

Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective european multi-center cohort.

Eur Urol. 2014 Jul;66(1):156-63

 

Klatte T, Xylinas E, Rieken M, Rouprêt M, Fajkovic H, Seitz C, Karakiewicz PI, Lotan Y, Babjuk M, de Martino M, Shariat SF. Effect of ABO blood type on mortality in patients with urothelial carcinoma of   the bladder treated with radical cystectomy. Urol Oncol. 2014 Feb 1 [Epub ahead of print].

 

Lucca I, Rouprêt M, Kluth L, Rink M, Tilki D, Fajkovic H, Kassouf W, Hofbauer  SL, de Martino M, Karakiewicz PI, Briganti A, Trinh QD, Seitz C, Fritsche HM, Burger M, Lotan Y, Kramer G, Shariat SF, Klatte T. Adjuvant cisplatin-based   combination chemotherapy for lymph node-positive urothelial carcinoma of the   bladder following radical cystectomy: a retrospective international study of   more than 1500 patients. BJU Int. 2014 Jun 6. doi: 10.1111/bju.12829. [Epub   ahead of print].

 
Lucca I, Kassouf W, Kapoor A, Fairey A, Rendon RA, Izawa JI, Black PC,   Fajkovic H, Seitz C, Remzi M, Nyirády P, Rouprêt M, Margulis V, Lotan Y, de   Martino M, Hofbauer SL, Karakiewicz PI, Briganti A, Novara G, Shariat SF,   Klatte T. The role of adjuvant chemotherapy for lymph node-positive upper   tract urothelial carcinoma following radical nephroureterectomy: a retrospective   study. BJU Int. 2014 May 13. doi: 10.1111/bju.12801. [Epub ahead of print]
 
Rieken M, Schubert T, Xylinas E, Kluth L, Rouprêt M, Trinh QD, Lee RK, Al   Hussein Al Awamlh B, Fajkovic H, Novara G, Margulis V, Lotan Y, Martinez-  Salamanca JI, Matsumoto K, Seitz C, Remzi M, Karakiewicz PI, Scherr DS,   Briganti A, Bachmann A, Shariat SF; for the UTUC Collaboration. Association of perioperative blood transfusion with oncologic outcomes after radical   nephroureterectomy for upper tract urothelial carcinoma. Eur J Surg Oncol.   2014 Apr 13. pii: S0748-7983(14)00380-1. doi: 10.1016/j.ejso.2014.03.018.   [Epub ahead of print]

 

Nuhn P, Novara G, Seitz C, Gupta A, Matsumoto K, Kassouf W, Walton TJ, Fritsche HM, Tritschler S, Martínez-Salamanca JI, Ficarra V, Karakiewicz PI, Mazzoleni G, Shariat SF, Bastian PJ. Prognostic value of prior history of urothelial carcinoma of the bladder in patients with upper urinary tract   urothelial carcinoma: results from a retrospective multicenter study.

World J Urol. 2014 Jul 22. [Epub ahead of print]

 
Haddad AQ, Kapur P, Singla N, Raman JD, Then MT, Nuhn P, Buchner A, Bastian P, Seitz C, Shariat SF, Bensalah K, Rioux-Leclercq N, Sagalowsky A, Lotan Y, Margulis V. Conditional Survival After Radical Nephroureterectomy for Upper Tract Carcinoma. Eur Urol. 2014 Aug 18. pii: S0302-2838(14)00745-3.

 


Interstitielle Cystitis

Wammack R, Remzi M, Seitz C, Djavan B, Marberger M. Efficacy of
Oral Doxepin and Piroxicam Treatment for Interstitial Cystitis.
European Urology 2002 41:596-601.



Inkontinenz

Signorello D, Seitz C, Berner L, Trenti E, Martini T, Galantini A, Lusuardi L, Lodde M, Pycha A. Impact of Sacral Neuromodulation on Female Sexual Function and His Correlation with Clinical Outcome and Quality of Life Indexes: A Monocentric Experience.
J Sex Med. 2011 Jan 26.



Berger A, Seitz C, Hobisch A.

Single institution experience with the transobturator sling suspension system   AdVance® in the treatment of male urinary incontinence: mid-term results.

Int Braz J Urol. 2011 Jul-Aug;37(4):488-94.